Gene and Cell Therapy: New Findings from Medical Research and Treatment
A special issue of International Journal of Translational Medicine (ISSN 2673-8937).
Deadline for manuscript submissions: 31 October 2025 | Viewed by 61
Special Issue Editors
Interests: cancer; microbiome; oncolytic adenoviruses
Interests: adoptive cancer immunotherapy; gene therapy; hematopoietic stem cell transplantation
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Gene and cell therapies could be employed to treat single-gene disorders, polygenic disorders, various forms of cancer, vascular diseases, neurodegenerative disorders, inflammatory conditions, and acquired diseases. This may promote the development of precision medicine and transform traditional medicine. Personalized treatment plans can be formulated by considering the optimal treatment effect according to the genes, microbiome composition, environment, and lifestyle of the patient.
This Special Issue aims to present research on personalized medicine that expands our understanding of cancer biology and enables us to identify which patient populations may benefit from treatments.
We therefore welcome the submission of articles that design targeted therapeutic solutions and propose predictive biomarkers by investigating the molecular and functional properties of different cancers.
Within the field of oncology, several approaches to the targeting of cancer are available, and each are associated with distinct mechanisms of action. Recent advancements have expanded the scope and effectiveness of these therapies, improving patient outcomes by addressing critical challenges such as precision, targeting, and delivery.
The scope of this Special Issue includes, but is not limited to, the following topics:
- Immunotherapy;
- Adoptive Cell Therapy;
- Stem Cell Therapy;
- Tumor microbiome ;
- Tissue Engineering and Regenerative Medicine;
- Epigenetics and Stem Cell Biology;
- Biomarkers;
- Viral Vector;
- Bacterial Vector;
- Genome Editing;
- Oncolytic Viruses;
- RNA Therapeutics;
- Vaccines.
Dr. Lorella Tripodi
Dr. Antonio Di Stasi
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Translational Medicine is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cell therapy
- gene therapy
- chimeric antigen receptor T-cell immunotherapy
- oncolitic viruses OVs
- cancer treatment
- engineered mesenchymal stem cells (EMSCs)
- RNA therapeutics
- CRISPR-Cas9 gene editing
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
